Dr. Bradley Quon is a clinician-scientist with advanced training in biomarker research, epidemiology, and clinical respirology/cystic fibrosis. Dr. Quon received his BSc at the University of British Columbia (UBC) in Microbiology and Immunology. He completed the combined MD/MBA program at McGill University. Subsequently, he completed residency training in Internal Medicine and fellowship training in Respirology at UBC. Following completion of clinical training, he undertook two years of formal clinical research training in cystic fibrosis at the University of Washington.
Dr. Quon is currently Assistant Professor of Medicine and Principal Investigator at the University of British Columbia Centre for Heart and Lung Innovation. He holds an MSFHR Scholar award. The overarching goal of his research program is to discover, validate, and implement blood-based biomarkers to aid in the prediction, diagnosis and treatment of pulmonary exacerbations in cystic fibrosis (CF). He is also interested in using population-based registry data to predict and better understand health outcomes in CF.
For an up-to-date list of publications by Dr. Quon, please see PubMed.